Randomized Phase 3 Study evaluating the efficacy and safety of nivolumab vs. bevacizumab in patients with recurrent glioblastoma: CheckMate 143 - Reardon, D A; Omuro, A; Brandes, A A (Neuro-Oncology, 2017)